Role of alternative splicing of periostin in human bladder carcinogenesis

International Journal of Oncology

Volumn 32, Issue 1, 2008, Pages 161-169

  Kim, Chul Jang ^a   Isono, Takahiro ^b   Tambe, Yukihiro ^b   Chano, Tokuhiro ^b   Okabe, Hidetoshi ^b   Okada, Yusaku ^b   Inoue, Hirokazu ^b  

^a Kohka Public Hospital   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Alternative splicing; Bladder cancer; Invasion; Metastasis; Periostin

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR RUNX2; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; BLADDER EPITHELIUM; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTECTOMY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN VARIANT; STROMA; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; WILD TYPE;

EID: 38649109196     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.32.1.161     Document Type: Article

References (27)

1. Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, Toyama Y, Bonewald LF and Kudo A: Identification and characterization of a novel protein, periostin, with restricted expression to periostium and periodontal ligament and increased expression by transforming growth factor B. J Bone Miner Res 14: 1239-1249, 1999.
2. Katsuragi N, Morishita R, Nakamura N, Ochiai T, Taniyama Y, Hasegawa Y, Kawashima K, Kaneda Y, Ogihara T and Sugimura K: Periostin as a novel factor responsible for ventricular dilation. Circulation 110: 1806-1813, 2004.
3. Wang D, Oparil S, Feng JA, Li P, Perry G, Chen LB, Dai M, John SW and Chen YF: Effects of pressure overload on extra-cellular matrix expression in the heart of the atrial natriuretic peptide-null mouse. Hypertension 42: 88-95, 2003.
4. Wilde J, Yokozeki M, Terai K, Kudo A and Moriyama K: The divergent expression of periostin mRNA in the periodontal ligament during experimental tooth movement. Cell Tissue Res 312: 345-351, 2003.
5. Rios H, Koushik SV, Wang H, Wang J, Zhou HM, Lindsley A, Rogers R, Chen Z, Maeda M, Kruzynska-Frejtag A, Feng JQ and Conway SJ: Periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol Cell Biol 25: 11131-11144, 2005.
6. Takeshita S, Kikuno R, Tezuka K and Amann E: Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J 294: 271-278, 1993.
7. Skonier J, Neubauer M, Madisen L, Bennett K, Plowman GD and Purchio AF: cDNA cloning and sequence analysis of Big-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-β. DNA Cell Biol 11: 511-522, 1992.
8. LeBaron RG, Bezverkov KI, Zimber MP, Pavelec R, Skonier J and Purchio AF: βIG-H3, a novel secretory protein inducible by transforming growth factor-β, is present in normal skin and promotes the cell adhesion and spreading of dermal fibroblasts in vitro. J Invest Dermatol 104: 844-849, 1995.
9. Ohno S, Noshiro M, Makihira S, Kawamoto T, Shen M, Yan W, Kawashima-Ohya Y, Fujimoto K, Tanne K and Kato Y: RGD-CAP (βig-h3) enhances the spreading of chondrocytes and fibroblasts via integrin α1β1. Biochim Biophys Acta 1451: 196-205, 1999.
10. Skonier J, Bennett K, Rothwell V, Kosowski S, Plowman G, Wallace P, Edelhoff S, Disteche C, Neubauer M, Marquardt H, Rodgers I and Purchio AF: βig-h3: A transforming growth factor-β-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol 13: 571-584, 1994.
11. Haertel-Wiesmann M, Liang Y, Fantl WJ and Williams LT: Regulation of cyclooxygenase-2 and periostin by Wnt-3 in mouse mammary epithelial cells. J Biol Chem 275: 32046-32051, 2000.
12. Bao S, Ouyang G, Bai X, Huang Z, Ma C, Liu M, Shao R, Anderson RM, Rich JN and Wang XF: Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell 5: 329-339, 2004.
13. Shao R, Bao S, Bai X, Blanchette C, Anderson RM, Dang T, Gishizky ML, Marks JR and Wang XF: Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor 2 expression. Mol Cell Biol 24: 3992-4003, 2004.
14. Sasaki H, Lo KM, Chen LB, Auclair D, Nakashima Y, Moriyama S, Fukai I, Tam C, Loda M and Fuji Y: Expression of periostin, homologous with an insect cell adhesion molecule, as a prognostic marker in non-small cell lung cancers. Jpn J Cancer Res 92: 869-873, 2001.
15. Kudo Y, Ogawa I, S. Kitajima S, Kitagawa M, Kawai H, Gaffney PM, Miyauchi M and Takata T: Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res 66: 6928-6935, 2006.
16. Siriwardena BSMS, Kudo Y, Ogawa I, Kitagawa M, Kitajima S, Hatano H, Tilakaratne WM, Miyauchi M and Takata T: Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. Br J Cancer 95: 1396-1403, 2006.
17. Baril P, Gangeswaran R, Mahon PC, Caulee K, Kocher HM, Harada T, Zhu M, Kalthoff H, Crnogorac-Jurcevic T and Lemoine NR: Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the β4 integrin and the PI3k pathway. Oncogene 26: 2082-2094, 2007.
18. Kim CJ, Yoshioka N, Tambe Y, Kushima R, Okada Y and Inoue H: Periostin is down-regulated in high grade bladder cancer and suppress in vitro cell invasiveness and in vivo metastasis of cancer cells. Int J Cancer 117: 51-58, 2005.
19. Yoshioka N, Inoue H, Nakanishi K, Oka K, Yutsudo M, Yamashita A, Hakura A and Nojima H: Isolation of transformation suppressor genes by cDNA subtraction: lumican suppresses transformation induced by v-src and v-K-ras. J Virol 74: 1008-1013, 2000.
20. Yoshioka N, Fuji S, Shimakage M, Kodama K, Hakura A, Yutsudo M, Inoue H and Nojima H: Suppression of anchorage-independent growth of human cancer cell lines by the TR1F52/Periostin/OSF-2 gene. Exp Cell Res 279: 91-99, 2002.
21. Litvin J, Blagg A, Mu A, Mitiwala S, Montgomery M, Berretta R, Houser S and Marqulies K: Periostin and periostin-like factor in the human heart: possible therapeutic targets. Cardiovasc Pathol 15: 24-32, 2006.
22. Litvin J, Selim AH, Montgomery MO, Lehmann K, Rico MC, Devlin H, Bednarik DP and Safadi FF: Expression and function of periostin-isoforms in bone. J Cell Biochem 92: 1044-1061, 2004.
23. Tanaka T, Isono T, Yoshiki T, Yuasa T and Okada Y: A novel form of prostate-specific antigen transcript produced by alternative splicing. Cancer Res 60: 56-59, 2000.
24. Sanger F, Nicklens S and Coulson AR: DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 74: 5463-5467, 1977.
25. Akagi T, Shishido T, Murata K and Hanafusa H: v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation. Proc Natl Acad Sci USA 97: 7290-7295, 2000.
26. Lee JH, Seo YW, Park SR, Kim YJ and Kim KK: Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression. Cancer Res 63: 7247-7255, 2003.
27. Song SW, Fuller GN, Zheng H and Zhang W: Inactivation of the invasion inhibitory gene IIp45 by alternative splicing in gliomas. Cancer Res 65: 3562-3567, 2005.